首页> 外文OA文献 >Analysis of efficacy and safety of dulaglutide 0.75 mg stratified by sex in patients with type 2 diabetes in 2 randomized, controlled phase 3 studies in Japan

【2h】

Analysis of efficacy and safety of dulaglutide 0.75 mg stratified by sex in patients with type 2 diabetes in 2 randomized, controlled phase 3 studies in Japan

机译：2型糖尿病患者2型糖尿病患者分层的乳糖蛋白质疗效和安全性分析，日本2型糖尿病患者分层

代理获取

本网站仅为用户提供外文OA文献查询和代理获取服务，本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文，但由于OA文献来源多样且变更频繁，仍可能出现获取不到、文献不完整或与标题不符等情况，如果获取不到我们将提供退款服务。请知悉。

页面导航

著录项
引文网络
相似文献
相关主题

著录项

作者
Yukiko Onishi; Tomonori Oura; Akiko Matsui; Jun Matsuura; Noriyuki Iwamoto;
展开▼
作者单位

展开▼
年度 2017
总页数
原文格式 PDF
正文语种
中图分类

相似文献

外文文献
中文文献
专利

1. Analysis of efficacy and safety of dulaglutide 0.75 mg stratified by sex in patients with type 2 diabetes in 2 randomized, controlled phase 3 studies in Japan [J] . Yukiko Onishi, Tomonori Oura, Akiko Matsui, Endocrine journal . 2017,第5期

机译：在日本的2项随机，对照的3期随机对照研究中，按性别分层分析了度拉鲁肽0.75 mg在2型糖尿病患者中的疗效和安全性
2. Efficacy and safety of subgroup analysis stratified by baseline HbA1c in a Japanese phase 3 study of dulaglutide 0.75 mg compared with insulin glargine in patients with type 2 diabetes [J] . Shizuka Kaneko, Tomonori Oura, Akiko Matsui, Endocrine journal . 2017,第12期

机译：在0.75 mg dulaglutide与甘精胰岛素比较的日本3期研究中，以基线HbA1c分层的亚组分析的有效性和安全性在2型糖尿病患者中
3. Safety and efficacy of oral semaglutide versus dulaglutide in Japanese patients with type 2 diabetes (PIONEER 10): an open-label, randomised, active-controlled, phase 3a trial [J] . The lancet. Diabetes & endocrinology. . 2020,第5期

机译：口腔半蛋白质的安全性和疗效与日本患者2型糖尿病患者（先锋10）：开放式，随机，主动控制，相3A试验
4. A Randomized, Placebo-Controlled Study of the Efficacy of Cognitive Intervention on Elderly People and on Patient's with Alzheimer's Disease [C] . J.J. Yanguas, C. Buiza, I. Etxeberria, International Conference on Computers Helping People with Special Needs(ICCHP 2006); 20060711-13; Linz(AT) . 2006

机译：认知干预对老年人和阿尔茨海默氏病患者疗效的随机，安慰剂对照研究
5. Recruitment, retention and compliance in randomized, phase III clinical trials involving obese patients diagnosed with type 2 Diabetes Mellitus with respect to weight loss practicum report. [D] . Mithani, Moez S. 2012

机译：涉及诊断为2型糖尿病的肥胖患者的有关减肥实践的随机III期临床试验中的招募，保留和依从性报告。
6. Efficacy and safety of once‐weekly dulaglutide in combination with sulphonylurea and/or biguanide compared with once‐daily insulin glargine in Japanese patients with type 2 diabetes: a randomized open‐label phase III non‐inferiority study [O] . E. Araki, N. Inagaki, Y. Tanizawa, -1

机译：在日本2型糖尿病患者中每周一次dulaglutide联合磺脲类和/或双胍联合每日一次甘精胰岛素的疗效和安全性：一项随机开放标签III期非劣效性研究
7. Efficacy and safety of subgroup analysis stratified by baseline HbA1c in a Japanese phase 3 study of dulaglutide 0.75 mg compared with insulin glargine in patients with type 2 diabetes [O] . Shizuka Kaneko, Tomonori Oura, Akiko Matsui, 2017

机译：基线HBA1C分层分层的疗效和安全性在日本第3型糖尿病患者患有2型糖尿病患者胰岛素狼原体的日语第3阶段第3阶段研究

Analysis of efficacy and safety of dulaglutide 0.75 mg stratified by sex in patients with type 2 diabetes in 2 randomized, controlled phase 3 studies in Japan

著录项

引文网络

相似文献

相关主题

期刊订阅